Incidental enhancing lesions found on preoperative breast MRI: management and role of second-look ultrasound

2011 ◽  
Vol 116 (6) ◽  
pp. 886-904 ◽  
Author(s):  
M. L. Luciani ◽  
F. Pediconi ◽  
M. Telesca ◽  
F. Vasselli ◽  
V. Casali ◽  
...  
2015 ◽  
Vol 204 (3) ◽  
pp. W357-W362 ◽  
Author(s):  
Se Jin Nam ◽  
Eun-Kyung Kim ◽  
Min Jung Kim ◽  
Hee Jung Moon ◽  
Jung Hyun Yoon

2019 ◽  
Vol 4 (3) ◽  
pp. 368
Author(s):  
AhmedM. A. Ahmed ◽  
TarekA. M. Ahmed ◽  
MahmoudR Shehata ◽  
Marwa Makboul ◽  
MoahamedA. M. Ibrahem

2015 ◽  
Vol 25 (10) ◽  
pp. 2830-2839 ◽  
Author(s):  
Paola Clauser ◽  
Luca A. Carbonaro ◽  
Martina Pancot ◽  
Rossano Girometti ◽  
Massimo Bazzocchi ◽  
...  

2014 ◽  
Vol 20 (3) ◽  
pp. 243-248 ◽  
Author(s):  
Jacopo Nori ◽  
Icro Meattini ◽  
Elisabetta Giannotti ◽  
Dalmar Abdulcadir ◽  
Giovanna Mariscotti ◽  
...  

2013 ◽  
Vol 11 (1) ◽  
Author(s):  
Brigid K. Killelea ◽  
Baiba J. Grube ◽  
Muhammad Rishi ◽  
Liane Philpotts ◽  
Eliza-Jasmine Tran ◽  
...  

2015 ◽  
Vol 26 (1) ◽  
pp. 19-25
Author(s):  
Alan B. Hollingsworth ◽  
Rebecca G. Stough

2017 ◽  
Vol 68 (4) ◽  
pp. 401-408 ◽  
Author(s):  
Romuald Ferré ◽  
Shaza AlSharif ◽  
Ann Aldis ◽  
Benoît Mesurolle

Purpose The study sought to investigate the outcome of breast magnetic resonance–guided biopsies as a function of the indication for magnetic resonance imaging (MRI), the MRI features of the lesions, and the performance or not of a targeted second-look ultrasound (SLUS) prior breast MRI-guided biopsy. Methods We identified 158 women with MRI-detected breast lesions scheduled for MRI-guided biopsy (2007-2013). Patient demographics, performance of targeted SLUS, imaging characteristics, and subsequent pathology results were reviewed. Results Three biopsies were deferred, and 155 lesions were biopsied under MRI guidance (155 women; median age 55.14 years; range 27-80 years). Ninety-eight women underwent a SLUS prior to the MRI-guided biopsy (63%). Of the 155 biopsied lesions, 23 (15%) were malignant, 106 (68%) were benign, and 26 (17%) were high risk. Four of 15 surgically excised high-risk lesions were upgraded to malignancy (27%). Most of the biopsied lesions corresponded to non–mass-like enhancement (81%, 126 of 155) and most of the biopsies (52%, 81 of 155) were performed in a screening context. No demographic or MRI features were associated with malignancy. No differences were noted between the 2 subgroups (prior SLUS vs no prior SLUS) except for the presence of a synchronous carcinoma associated with a likelihood of targeted SLUS before MRI-guided biopsy ( P = .001). Conclusion A negative SLUS does not influence the pathology outcome of a suspicious lesion biopsied under MR guidance.


Author(s):  
Col (Dr.) Puneet Takkar ◽  
◽  
Surg Lt Cdr (Dr.) Hari JP ◽  
Surg Lt Cdr (Dr.) Khushdeep Kaur ◽  
◽  
...  

Sign in / Sign up

Export Citation Format

Share Document